Insider Shareholders with Direct Ownership of Lexeo Therapeutics, Inc. (LXEO)
This section provides a comprehensive overview of the insiders with direct ownership of Lexeo Therapeutics, Inc. (LXEO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Lexeo Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Omega Fund Vi, L.P.
> 10% Shareholder |
2,157,623 | 0 | 2,157,623 | 1 |
Nov 07, 2023
Added 17.4%
|
|
Invest A/S Lundbeckfond
> 10% Shareholder |
1,835,959 | 0 | 1,835,959 | 1 |
Nov 07, 2023
Added 11.02%
|
|
Richard Nolan Townsend
Chief Executive Officer |
184,628 | 93,135 | 220,058 | 23 |
Aug 18, 2025
Reduced 1.23%
|
|
Eric Adler
Chief Medical Officer |
70,625 | 3,552 | 67,073 | 5 |
Aug 18, 2025
Reduced 0.9%
|
|
Jenny Robertson
Chief Legal Officer |
65,720 | 3,164 | 62,556 | 6 |
Aug 18, 2025
Reduced 0.86%
|
|
Jose Manuel Otero
Chief Technical Officer |
63,220 | 2,848 | 60,372 | 4 |
Aug 18, 2025
Reduced 4.5%
|
|
Tai Sandi See
Chief Development Officer |
44,470 | 2,235 | 58,860 | 5 |
Aug 18, 2025
Reduced 0.64%
|
|
Louis Edward Tamayo
Chief Financial Officer |
45,000 | 0 | 45,000 | 1 |
Aug 29, 2025
Added 50.0%
|
|
Kyle Rasbach
Chief Financial Officer |
40,875 | 0 | 40,875 | 1 |
Jan 17, 2025
Added 50.0%
|
| 15,000 | 0 | 30,627 | 1 |
Nov 25, 2024
Added 32.88%
|
|
|
Paul Mc Cormac
Chief Technical Officer |
3,191 | 0 | 17,349 | 1 |
Nov 07, 2023
Added 15.54%
|